Computer-aided drug design for virtual-screening and active-predicting of main protease (Mpro) inhibitors against SARS-CoV-2
Introduction: SARS-CoV-2 is a novel coronavirus with highly contagious and has posed a significant threat to global public health. The main protease (Mpro) is a promising target for antiviral drugs against SARS-CoV-2.Methods: In this study, we have used pharmacophore-based drug design technology to...
Saved in:
Main Authors: | Renhui Dai (Author), Hongwei Gao (Author), Ruiling Su (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
by: Soumya Gulab Katre, et al.
Published: (2022) -
In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020) -
In silico investigation of HCV and RNA synthesis inhibitor antibiotic drugs as potential inhibitors of SARS‑CoV‑2 main protease (Mpro)
by: Merusomayajula V. Kishore, et al.
Published: (2024) -
The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study
by: Mateus Sá Magalhães Serafim, et al.
Published: (2023) -
Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection
by: Zhen Xu, et al.
Published: (2022)